Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks

摘要

A combination of the following components for simultaneous, separate or sequential administration is new: (a) an acetylcholinesterase inhibitor or compound with muscarinergic activity, (b) a compound that increases endogenous extracellular adenosine levels, and (c) a pharmaceutical carrier.